ARTELO BIOSCIENCES INC (ARTL) Stock Income Statement
NASDAQ:ARTL - Nasdaq - US04301G5080 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-8-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 9.90M | 10.00M | 9.93M | 10.29M | 7.44M | |||
| Research and Development | 5.87M | N/A | 5.70M | 4.32M | 2.84M | |||
| Selling, General, and Administrative Expenses | 4.03M | 4.12M | 4.23M | 5.96M | 4.60M | |||
| Operating Income | -9.90M | -10.00M | -9.93M | -10.29M | -7.44M | |||
| Interest Income/Expense | 183.00K | N/A | 641.00K | 200.00K | 0.00 | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Income Before Taxes | -9.71M | -9.83M | -9.29M | -10.08M | -7.44M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -9.71M | -9.83M | -9.29M | -10.08M | -7.44M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -17.90 | -18.29 | -18.83 | -21.34 | -5.97 | |||
| Non GAAP EPS | -17.94 | -18.30 | -19.14 | -21.90 | -0.29 | |||
| Statistics | ||||||||
All data in USD